Back to Careers
Juvena Therapeutics Raises $33.5M Series B Led by Bison Ventures to Advance Regenerative Biologics Pipeline
Back to Careers
CEO Dr. Hanadie Yousef shares more about our JuvNET Platform as an invited seminar speaker for Stanford’s CS 522: Artificial Intelligence in Healthcare course
Back to Careers
CEO, Dr. Hanadie Yousef, joined the Impact a Billion Summit by Transform VC to share how Juvena is using AI and protein science to advance muscle-regenerating therapeutics that promote strength, independence, and healthy aging
Back to Careers
CEO, Dr. Hanadie Yousef, had a rewarding experience moderating and participating in the panel titled “Rethinking Platform Biotech: How Emerging Innovators Are Structuring the Future of Pharma Collaboration” last week at Fierce Biotech Week
Back to Careers
AI Excellence: Juvena’s JuvNET Platform Recognized as CEO Dr. Yousef Makes Prestigious Mayfield | Divot AI List
Back to Careers
CEO Dr. Hanadie Yousef featured on Biotech TV’s Biotech CEO Sisterhood series at the NYSE, spotlighting Juvena’s leadership in protein-based therapeutics for muscle and metabolic disease
Back to Careers
CEO Dr. Hanadie Yousef delivered a seminar at the Buck Institute as a distinguished guest speaker highlighting Juvena’s pioneering work in regenerative biologics and AI-driven drug discovery
Back to Careers
Juvena Therapeutics presented JUV-161 and JUV-112, at ENDO2025, earning recognition from the Endocrine Society for innovation in metabolic and endocrine health
Back to Careers
Juvena Therapeutics’ Partnership with Eli Lilly Featured in Nature Biotechnology for Enhancing Muscle Health and Body Composition
Back to Careers
Pharmaphorum Spotlights Juvena’s AI Platform for Muscle and Metabolic Regeneration in Interview with CEO, Dr. Hanadie Yousef
